These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8043542)
41. [Evaluation of myometrial invasion in endometrial carcinoma]. Peng P; Shen K; Lang J; Huang H; Wu M; Cui Q; Jiang Y; Tan L Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):679-82. PubMed ID: 12487925 [TBL] [Abstract][Full Text] [Related]
42. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma]. Xue F; Jiao S; Zhao F Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776 [TBL] [Abstract][Full Text] [Related]
43. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. Yamashita Y; Mizutani H; Torashima M; Takahashi M; Miyazaki K; Okamura H; Ushijima H; Ohtake H; Tokunaga T AJR Am J Roentgenol; 1993 Sep; 161(3):595-9. PubMed ID: 8352114 [TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor and intratumoral microvessel density as prognostic factors in endometrial cancer. Topolovec Z; Corusić A; Babić D; Mrcela M; Sijanović S; Müller-Vranjes A; Curzik D Coll Antropol; 2010 Jun; 34(2):447-53. PubMed ID: 20698116 [TBL] [Abstract][Full Text] [Related]
45. Assessment of myometrial invasion in endometrial cancer by transvaginal sonography, Doppler ultrasonography, magnetic resonance imaging and frozen section. Ozdemir S; Celik C; Emlik D; Kiresi D; Esen H Int J Gynecol Cancer; 2009 Aug; 19(6):1085-90. PubMed ID: 19820373 [TBL] [Abstract][Full Text] [Related]
46. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
47. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images. Utsunomiya D; Notsute S; Hayashida Y; Lwakatare F; Katabuchi H; Okamura H; Awai K; Yamashita Y AJR Am J Roentgenol; 2004 Feb; 182(2):399-404. PubMed ID: 14736670 [TBL] [Abstract][Full Text] [Related]
48. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503 [TBL] [Abstract][Full Text] [Related]
51. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP Gynecol Oncol; 2007 Mar; 104(3):654-9. PubMed ID: 17095081 [TBL] [Abstract][Full Text] [Related]
52. Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection. Teefey SA; Stahl JA; Middleton WD; Huettner PC; Bernhard LM; Brown JJ; Hildebolt CF; Mutch DG AJR Am J Roentgenol; 1996 Mar; 166(3):547-52. PubMed ID: 8623626 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of DNA ploidy in endometrial cancer. Ikeda M; Watanabe Y; Nanjoh T; Noda K Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160 [TBL] [Abstract][Full Text] [Related]
54. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection]. Ivanov I Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272 [TBL] [Abstract][Full Text] [Related]
55. [Prognostic factors in endometrial cancer. A retrospective study based on 564 patients]. Bamert M; Rageth C; Steiner R Gynakol Geburtshilfliche Rundsch; 1992; 32(2):78-83. PubMed ID: 1392632 [TBL] [Abstract][Full Text] [Related]
56. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma. Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832 [TBL] [Abstract][Full Text] [Related]
57. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Lukes AS; Kohler MF; Pieper CF; Kerns BJ; Bentley R; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC; Berchuck A Cancer; 1994 May; 73(9):2380-5. PubMed ID: 7909491 [TBL] [Abstract][Full Text] [Related]
58. Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer. Mangili G; De Marzi P; Viganò R; Rabaiotti E; Sassi I; Taccagni GL; Garancini P; Frigerio L Eur J Gynaecol Oncol; 2002; 23(3):216-20. PubMed ID: 12094958 [TBL] [Abstract][Full Text] [Related]
59. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Nakao Y; Yokoyama M; Hara K; Koyamatsu Y; Yasunaga M; Araki Y; Watanabe Y; Iwasaka T Gynecol Oncol; 2006 Aug; 102(2):343-7. PubMed ID: 16469365 [TBL] [Abstract][Full Text] [Related]
60. [Prognostic survival of women after surgery for endometrial cancer]. Roszak A Ginekol Pol; 1994 Sep; 65(9):486-90. PubMed ID: 7721160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]